418 related articles for article (PubMed ID: 25539367)
1. [18F]-Fluoromisonidazole positron emission tomography/computed tomography visualization of tumor hypoxia in patients with chordoma of the mobile and sacrococcygeal spine.
Cheney MD; Chen YL; Lim R; Winrich BK; Grosu AL; Trofimov AV; Depauw N; Shih HA; Schwab JH; Hornicek FJ; DeLaney TF
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1030-6. PubMed ID: 25539367
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography/computed tomography imaging of residual skull base chordoma before radiotherapy using fluoromisonidazole and fluorodeoxyglucose: potential consequences for dose painting.
Mammar H; Kerrou K; Nataf V; Pontvert D; Clemenceau S; Lot G; George B; Polivka M; Mokhtari K; Ferrand R; Feuvret L; Habrand JL; Pouysségur J; Mazure N; Talbot JN
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):681-7. PubMed ID: 22391104
[TBL] [Abstract][Full Text] [Related]
3. Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study.
Lee NY; Mechalakos JG; Nehmeh S; Lin Z; Squire OD; Cai S; Chan K; Zanzonico PB; Greco C; Ling CC; Humm JL; Schöder H
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):2-13. PubMed ID: 17869020
[TBL] [Abstract][Full Text] [Related]
4. [18F]fluoromisonidazole and a new PET system with semiconductor detectors and a depth of interaction system for intensity modulated radiation therapy for nasopharyngeal cancer.
Yasuda K; Onimaru R; Okamoto S; Shiga T; Katoh N; Tsuchiya K; Suzuki R; Takeuchi W; Kuge Y; Tamaki N; Shirato H
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):142-7. PubMed ID: 22583608
[TBL] [Abstract][Full Text] [Related]
5. Local relapse of nasopharyngeal cancer and Voxel-based analysis of FMISO uptake using PET with semiconductor detectors.
Nishikawa Y; Yasuda K; Okamoto S; Ito YM; Onimaru R; Shiga T; Tsuchiya K; Watanabe S; Takeuchi W; Kuge Y; Peng H; Tamaki N; Shirato H
Radiat Oncol; 2017 Sep; 12(1):148. PubMed ID: 28877734
[TBL] [Abstract][Full Text] [Related]
6. F-18 FDG PET/CT evaluation of sacrococcygeal chordoma.
Park SA; Kim HS
Clin Nucl Med; 2008 Dec; 33(12):906-8. PubMed ID: 19033806
[TBL] [Abstract][Full Text] [Related]
7. Updated Outcome and Analysis of Tumor Response in Mobile Spine and Sacral Chordoma Treated With Definitive High-Dose Photon/Proton Radiation Therapy.
Kabolizadeh P; Chen YL; Liebsch N; Hornicek FJ; Schwab JH; Choy E; Rosenthal DI; Niemierko A; DeLaney TF
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):254-262. PubMed ID: 27986348
[TBL] [Abstract][Full Text] [Related]
8. ¹⁸F-HX4 hypoxia imaging with PET/CT in head and neck cancer: a comparison with ¹⁸F-FMISO.
Chen L; Zhang Z; Kolb HC; Walsh JC; Zhang J; Guan Y
Nucl Med Commun; 2012 Oct; 33(10):1096-102. PubMed ID: 22836736
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas.
DeLaney TF; Liebsch NJ; Pedlow FX; Adams J; Weyman EA; Yeap BY; Depauw N; Nielsen GP; Harmon DC; Yoon SS; Chen YL; Schwab JH; Hornicek FJ
J Surg Oncol; 2014 Aug; 110(2):115-22. PubMed ID: 24752878
[TBL] [Abstract][Full Text] [Related]
10. Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy.
Lee N; Nehmeh S; Schöder H; Fury M; Chan K; Ling CC; Humm J
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):101-8. PubMed ID: 19203843
[TBL] [Abstract][Full Text] [Related]
11. Overlap of highly FDG-avid and FMISO hypoxic tumor subvolumes in patients with head and neck cancer.
Mönnich D; Thorwarth D; Leibfarth S; Pfannenberg C; Reischl G; Mauz PS; Nikolaou K; la Fougère C; Zips D; Welz S
Acta Oncol; 2017 Nov; 56(11):1577-1582. PubMed ID: 28849721
[TBL] [Abstract][Full Text] [Related]
12. Proton therapy for reirradiation of progressive or recurrent chordoma.
McDonald MW; Linton OR; Shah MV
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1107-14. PubMed ID: 24267972
[TBL] [Abstract][Full Text] [Related]
13. High-dose proton-based radiation therapy in the management of spine chordomas: outcomes and clinicopathological prognostic factors.
Rotondo RL; Folkert W; Liebsch NJ; Chen YL; Pedlow FX; Schwab JH; Rosenberg AE; Nielsen GP; Szymonifka J; Ferreira AE; Hornicek FJ; DeLaney TF
J Neurosurg Spine; 2015 Dec; 23(6):788-97. PubMed ID: 26340383
[TBL] [Abstract][Full Text] [Related]
14. 18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma.
Kikuchi M; Yamane T; Shinohara S; Fujiwara K; Hori SY; Tona Y; Yamazaki H; Naito Y; Senda M
Ann Nucl Med; 2011 Nov; 25(9):625-33. PubMed ID: 21720778
[TBL] [Abstract][Full Text] [Related]
15. Detection of hypoxia with 18F-fluoromisonidazole (18F-FMISO) PET/CT in suspected or proven pancreatic cancer.
Segard T; Robins PD; Yusoff IF; Ee H; Morandeau L; Campbell EM; Francis RJ
Clin Nucl Med; 2013 Jan; 38(1):1-6. PubMed ID: 23242037
[TBL] [Abstract][Full Text] [Related]
16. Spatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure.
Zschaeck S; Haase R; Abolmaali N; Perrin R; Stützer K; Appold S; Steinbach J; Kotzerke J; Zips D; Richter C; Gudziol V; Krause M; Zöphel K; Baumann M
Acta Oncol; 2015; 54(9):1355-63. PubMed ID: 26398663
[TBL] [Abstract][Full Text] [Related]
17. Sacrococcygeal chordoma: CT appearance after radiotherapy.
Hishikawa Y; Ishikura R; Kamikonya N; Tanaka S; Miura T
Radiat Med; 1985; 3(3):144-6. PubMed ID: 3834518
[TBL] [Abstract][Full Text] [Related]
18. A prospective clinical trial of tumor hypoxia imaging with 18F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) before and during radiation therapy.
Tachibana I; Nishimura Y; Shibata T; Kanamori S; Nakamatsu K; Koike R; Nishikawa T; Ishikawa K; Tamura M; Hosono M
J Radiat Res; 2013 Nov; 54(6):1078-84. PubMed ID: 23589026
[TBL] [Abstract][Full Text] [Related]
19. A model of reoxygenation dynamics of head-and-neck tumors based on serial 18F-fluoromisonidazole positron emission tomography investigations.
Thorwarth D; Eschmann SM; Paulsen F; Alber M
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):515-21. PubMed ID: 17398015
[TBL] [Abstract][Full Text] [Related]
20. Planning study for available dose of hypoxic tumor volume using fluorine-18-labeled fluoromisonidazole positron emission tomography for treatment of the head and neck cancer.
Choi W; Lee SW; Park SH; Ryu JS; Oh SJ; Im KC; Choi EK; Kim JH; Jung SH; Kim S; Ahn SD
Radiother Oncol; 2010 Nov; 97(2):176-82. PubMed ID: 20855118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]